Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
Oscient Factive discontinuedAnti-infectives for systemic use
Genzyme Fabrazyme Approved in USAAlimentary tract & metabolism
Nektar Therapeutics Exubera Approved in USA and EUAlimentary tract & metabolism
Pfizer Exubera Approved in USA and EUAlimentary tract & metabolism
Sanofi-aventis Exubera Submitted for approval in USA and EUAlimentary tract & metabolism
Novartis Exjade Approved in USA, submitted for approval in EUBlood & blood forming organs
Adherex Technologies Exherin in Phase IIAntineoplastic & immunomodulating agents
Novartis Exforge Approved in EU and USACardiovascular system
Novartis Exelon Approved in USANervous system
Dainippon Sumimoto Pharma Excegran Submitted for approval in JapanNervous system
AstraZeneca Exanta discontinuedBlood & blood forming organs
AstraZeneca Exanta discontinuedCardiovascular system
AstraZeneca Exanta discontinuedCardiovascular system
Genaera Evizon in Phase IIISensory organs
Lilly Evista Approved in USAMusculoskeletal system
Vivus Evamist Approved in USAGenito urinary system & sex hormones
MedImmune Ethyol in Phase IIAntineoplastic & immunomodulating agents
MedImmune Ethyol accomplished Phase IIIAlimentary tract & metabolism
GlaxoSmithKline Etaquine in Phase IIIAntiparasitic products
Solvay EstroGel Approved in USAGenito urinary system & sex hormones
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.